Safety issues with the ALK inhibitors in the treatment of NSCLC: A systematic review

Critical Reviews in Oncology/Hematology - Tập 134 - Trang 56-64 - 2019
Loay Kassem1, Kyrillus S. Shohdy1, Shaimaa Lasheen1, Omar Abdel-Rahman2, Ahmad Ali1, Raafat R. Abdel-Malek1
1Clinical Oncology Department, Kasr Alainy School of Medicine, Cairo University, Cairo, Egypt
2Clinical Oncology Department, Faculty of Medicine, Ain Shams University, Cairo, Egypt

Tài liệu tham khảo

Thông tin
Thông tin xuất bản

Critical Reviews in Oncology/Hematology

Tập 134

56-64

Thông tin tác giả